The nucleic acid extraction instruments and reagents market size has grown rapidly in recent years. It will grow from $4.97 billion in 2025 to $5.54 billion in 2026 at a compound annual growth rate (CAGR) of 11.5%. The growth in the historic period can be attributed to expansion of molecular diagnostics testing, increased use of PCR-based techniques, growth in genomics and proteomics research, rising adoption of automated laboratory workflows, availability of standardized extraction kits.
The nucleic acid extraction instruments and reagents market size is expected to see rapid growth in the next few years. It will grow to $8.78 billion in 2030 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, expansion of infectious disease testing, growing investments in genomics research, rising adoption of fully automated laboratory systems, increased focus on rapid diagnostic turnaround times. Major trends in the forecast period include increasing adoption of automated extraction systems, rising demand for high-throughput nucleic acid processing, growing use of magnetic bead-based extraction methods, expansion of integrated sample-to-result platforms, enhanced focus on extraction accuracy and reproducibility.
The rising incidence of chronic non-communicable diseases (NCDs) is anticipated to accelerate the expansion of the nucleic acid extraction instruments and reagents market in the coming years. Chronic non-communicable diseases are long-standing medical conditions such as cardiovascular disorders, cancers, chronic respiratory illnesses, and diabetes, which progress gradually and account for a substantial share of global illness and mortality. In this context, nucleic acid extraction instruments and reagents play a vital role, as they support molecular diagnostics, genetic and biomarker testing, pharmacogenomic assessments, and ongoing disease monitoring, enabling improved understanding and management of these conditions. For example, in October 2024, data from the Centers for Disease Control and Prevention, a United States-based government agency, reported that in 2023 cardiovascular diseases were responsible for 919,032 deaths, representing nearly one in every three fatalities. Coronary heart disease remained the most common type of heart disease, and approximately one in six cardiovascular-related deaths occurred among adults under 65 years of age. As a result, the growing burden of chronic non-communicable diseases is contributing to the increased demand for nucleic acid extraction instruments and reagents.
Major companies in the nucleic acid extraction instruments and reagents market are concentrating on developing innovative solutions, such as nucleic acid extraction systems, to highlight their commitment to innovation and address specific market demands. Nucleic acid extraction systems consist of a range of laboratory tools and technologies aimed at isolating and purifying nucleic acids (DNA and RNA) from biological samples like blood, tissues, cells, and other fluids. For example, in January 2024, LGC Biosearch Technologies, a biotechnology firm based in the UK, introduced the sbeadex Lightning nucleic acid extraction method. This method transforms DNA purification by allowing high-purity extraction from plant and animal samples in just five minutes. It streamlines the traditional five-step process into three steps - bind, wash, and elute - leading to a time reduction of up to 40 minutes per sample and a potential tenfold increase in throughput. The extracted DNA typically demonstrates high purity, with 260/280 ratios ranging from 1.7 to 2, making it suitable for applications like PCR and next-generation sequencing (NGS).
In February 2025, Bio-Rad Laboratories Inc., a United States-based biotechnology and life-science research company, completed the acquisition of Stilla Technologies SAS for USD 225 million, along with potential contingent milestone payments of up to USD 50 million. This acquisition is intended to strengthen Bio-Rad’s digital polymerase chain reaction (dPCR) capabilities by incorporating Stilla’s high-precision multiplex digital PCR platforms into its existing product portfolio. Stilla Technologies SAS, a France-based company, specializes in the development of digital PCR instruments and assays used in genomics research, rare mutation identification, liquid biopsy applications, and accurate nucleic acid quantification.
Major companies operating in the nucleic acid extraction instruments and reagents market are Thermo Fisher Scientific Inc., F Hoffmann-La Roche Ltd., Merck Group, Corning Incorporated, Agilent Technologies Inc., PerkinElmer, Beckman Coulter, Bio-Rad Laboratories Inc., Qiagen NV, Eppendorf AG, LGC Biosearch Technologies, Promega Corporation, RBC Bioscience Corp., Takara Bio Inc., Meridian Bioscience, Bioneer Corporation, Macherey-Nagel, New England Biolabs, Miltenyi Biotec, Omega Bio-tek, BioVision Inc., Norgen Biotek Corp., Biosan Laboratories Inc., G-Biosciences, ADS Biotec Inc., BioChain Institute Inc., Lucigen Corporation.
North America was the largest region in the nucleic acid extraction instruments and reagents market in 2025. The regions covered in the nucleic acid extraction instruments and reagents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the nucleic acid extraction instruments and reagents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the nucleic acid extraction instruments and reagents market by increasing costs of imported reagents, magnetic beads, precision plastics, sensors, and automated extraction equipment. Diagnostic laboratories and research institutions in North America and Europe are most affected due to reliance on imported consumables and instruments, while Asia-Pacific faces cost pressure on large-scale kit manufacturing. These tariffs are increasing testing costs and procurement budgets. However, they are also driving local reagent production, regional instrument assembly, and supply chain diversification for critical molecular diagnostic components.
The nucleic acid extraction instruments and reagents market research report is one of a series of new reports that provides nucleic acid extraction instruments and reagents market statistics, including nucleic acid extraction instruments and reagents industry global market size, regional shares, competitors with a nucleic acid extraction instruments and reagents market share, detailed nucleic acid extraction instruments and reagents market segments, market trends and opportunities, and any further data you may need to thrive in the nucleic acid extraction instruments and reagents industry. This nucleic acid extraction instruments and reagents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Nucleic acid extraction instruments and reagents encompass the tools and substances instrumental in isolating and purifying nucleic acids such as DNA or RNA from biological samples. These components are pivotal in molecular biology, genetics, and diagnostic labs, aiding in vital research and analysis.
These essential tools and substances come in various types, including instruments, spin columns, beads (including magnetic ones), automated nucleic acid extraction systems, extraction kits and reagents, and consumables. Instruments are devices serving multiple functions, such as measurement, analysis, or experimentation. Extraction methods such as DNA, RNA, or DNA/RNA extraction rely on solution-based or solid-phase-based techniques. These products cater to diverse end users such as academic research institutes, hospitals, diagnostic centers, pharmaceutical and biotechnology industries, and contract research organizations (CROs).
The nucleic acid extraction instruments and reagents market consists of revenues earned by entities by providing nucleic acid extraction instruments and reagents services such as data management and analysis, and laboratory information management systems. The market value includes the value of related goods sold by the service provider or included within the service offering. The nucleic acid extraction instruments and reagents market also includes sales of centrifuges, thermal cyclers, and robotic platforms, which are used in providing nucleic acid extraction instruments and reagents services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The nucleic acid extraction instruments and reagents market size is expected to see rapid growth in the next few years. It will grow to $8.78 billion in 2030 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, expansion of infectious disease testing, growing investments in genomics research, rising adoption of fully automated laboratory systems, increased focus on rapid diagnostic turnaround times. Major trends in the forecast period include increasing adoption of automated extraction systems, rising demand for high-throughput nucleic acid processing, growing use of magnetic bead-based extraction methods, expansion of integrated sample-to-result platforms, enhanced focus on extraction accuracy and reproducibility.
The rising incidence of chronic non-communicable diseases (NCDs) is anticipated to accelerate the expansion of the nucleic acid extraction instruments and reagents market in the coming years. Chronic non-communicable diseases are long-standing medical conditions such as cardiovascular disorders, cancers, chronic respiratory illnesses, and diabetes, which progress gradually and account for a substantial share of global illness and mortality. In this context, nucleic acid extraction instruments and reagents play a vital role, as they support molecular diagnostics, genetic and biomarker testing, pharmacogenomic assessments, and ongoing disease monitoring, enabling improved understanding and management of these conditions. For example, in October 2024, data from the Centers for Disease Control and Prevention, a United States-based government agency, reported that in 2023 cardiovascular diseases were responsible for 919,032 deaths, representing nearly one in every three fatalities. Coronary heart disease remained the most common type of heart disease, and approximately one in six cardiovascular-related deaths occurred among adults under 65 years of age. As a result, the growing burden of chronic non-communicable diseases is contributing to the increased demand for nucleic acid extraction instruments and reagents.
Major companies in the nucleic acid extraction instruments and reagents market are concentrating on developing innovative solutions, such as nucleic acid extraction systems, to highlight their commitment to innovation and address specific market demands. Nucleic acid extraction systems consist of a range of laboratory tools and technologies aimed at isolating and purifying nucleic acids (DNA and RNA) from biological samples like blood, tissues, cells, and other fluids. For example, in January 2024, LGC Biosearch Technologies, a biotechnology firm based in the UK, introduced the sbeadex Lightning nucleic acid extraction method. This method transforms DNA purification by allowing high-purity extraction from plant and animal samples in just five minutes. It streamlines the traditional five-step process into three steps - bind, wash, and elute - leading to a time reduction of up to 40 minutes per sample and a potential tenfold increase in throughput. The extracted DNA typically demonstrates high purity, with 260/280 ratios ranging from 1.7 to 2, making it suitable for applications like PCR and next-generation sequencing (NGS).
In February 2025, Bio-Rad Laboratories Inc., a United States-based biotechnology and life-science research company, completed the acquisition of Stilla Technologies SAS for USD 225 million, along with potential contingent milestone payments of up to USD 50 million. This acquisition is intended to strengthen Bio-Rad’s digital polymerase chain reaction (dPCR) capabilities by incorporating Stilla’s high-precision multiplex digital PCR platforms into its existing product portfolio. Stilla Technologies SAS, a France-based company, specializes in the development of digital PCR instruments and assays used in genomics research, rare mutation identification, liquid biopsy applications, and accurate nucleic acid quantification.
Major companies operating in the nucleic acid extraction instruments and reagents market are Thermo Fisher Scientific Inc., F Hoffmann-La Roche Ltd., Merck Group, Corning Incorporated, Agilent Technologies Inc., PerkinElmer, Beckman Coulter, Bio-Rad Laboratories Inc., Qiagen NV, Eppendorf AG, LGC Biosearch Technologies, Promega Corporation, RBC Bioscience Corp., Takara Bio Inc., Meridian Bioscience, Bioneer Corporation, Macherey-Nagel, New England Biolabs, Miltenyi Biotec, Omega Bio-tek, BioVision Inc., Norgen Biotek Corp., Biosan Laboratories Inc., G-Biosciences, ADS Biotec Inc., BioChain Institute Inc., Lucigen Corporation.
North America was the largest region in the nucleic acid extraction instruments and reagents market in 2025. The regions covered in the nucleic acid extraction instruments and reagents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the nucleic acid extraction instruments and reagents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the nucleic acid extraction instruments and reagents market by increasing costs of imported reagents, magnetic beads, precision plastics, sensors, and automated extraction equipment. Diagnostic laboratories and research institutions in North America and Europe are most affected due to reliance on imported consumables and instruments, while Asia-Pacific faces cost pressure on large-scale kit manufacturing. These tariffs are increasing testing costs and procurement budgets. However, they are also driving local reagent production, regional instrument assembly, and supply chain diversification for critical molecular diagnostic components.
The nucleic acid extraction instruments and reagents market research report is one of a series of new reports that provides nucleic acid extraction instruments and reagents market statistics, including nucleic acid extraction instruments and reagents industry global market size, regional shares, competitors with a nucleic acid extraction instruments and reagents market share, detailed nucleic acid extraction instruments and reagents market segments, market trends and opportunities, and any further data you may need to thrive in the nucleic acid extraction instruments and reagents industry. This nucleic acid extraction instruments and reagents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Nucleic acid extraction instruments and reagents encompass the tools and substances instrumental in isolating and purifying nucleic acids such as DNA or RNA from biological samples. These components are pivotal in molecular biology, genetics, and diagnostic labs, aiding in vital research and analysis.
These essential tools and substances come in various types, including instruments, spin columns, beads (including magnetic ones), automated nucleic acid extraction systems, extraction kits and reagents, and consumables. Instruments are devices serving multiple functions, such as measurement, analysis, or experimentation. Extraction methods such as DNA, RNA, or DNA/RNA extraction rely on solution-based or solid-phase-based techniques. These products cater to diverse end users such as academic research institutes, hospitals, diagnostic centers, pharmaceutical and biotechnology industries, and contract research organizations (CROs).
The nucleic acid extraction instruments and reagents market consists of revenues earned by entities by providing nucleic acid extraction instruments and reagents services such as data management and analysis, and laboratory information management systems. The market value includes the value of related goods sold by the service provider or included within the service offering. The nucleic acid extraction instruments and reagents market also includes sales of centrifuges, thermal cyclers, and robotic platforms, which are used in providing nucleic acid extraction instruments and reagents services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Nucleic Acid Extraction Instruments and Reagents Market Characteristics
3. Nucleic Acid Extraction Instruments and Reagents Market Supply Chain Analysis
4. Global Nucleic Acid Extraction Instruments and Reagents Market Trends and Strategies
5. Nucleic Acid Extraction Instruments and Reagents Market Analysis of End Use Industries
7. Global Nucleic Acid Extraction Instruments and Reagents Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Nucleic Acid Extraction Instruments and Reagents Total Addressable Market (TAM) Analysis for the Market
9. Nucleic Acid Extraction Instruments and Reagents Market Segmentation
10. Nucleic Acid Extraction Instruments and Reagents Market Regional and Country Analysis
11. Asia-Pacific Nucleic Acid Extraction Instruments and Reagents Market
12. China Nucleic Acid Extraction Instruments and Reagents Market
13. India Nucleic Acid Extraction Instruments and Reagents Market
14. Japan Nucleic Acid Extraction Instruments and Reagents Market
15. Australia Nucleic Acid Extraction Instruments and Reagents Market
16. Indonesia Nucleic Acid Extraction Instruments and Reagents Market
17. South Korea Nucleic Acid Extraction Instruments and Reagents Market
18. Taiwan Nucleic Acid Extraction Instruments and Reagents Market
19. South East Asia Nucleic Acid Extraction Instruments and Reagents Market
20. Western Europe Nucleic Acid Extraction Instruments and Reagents Market
21. UK Nucleic Acid Extraction Instruments and Reagents Market
22. Germany Nucleic Acid Extraction Instruments and Reagents Market
23. France Nucleic Acid Extraction Instruments and Reagents Market
24. Italy Nucleic Acid Extraction Instruments and Reagents Market
25. Spain Nucleic Acid Extraction Instruments and Reagents Market
26. Eastern Europe Nucleic Acid Extraction Instruments and Reagents Market
27. Russia Nucleic Acid Extraction Instruments and Reagents Market
28. North America Nucleic Acid Extraction Instruments and Reagents Market
29. USA Nucleic Acid Extraction Instruments and Reagents Market
30. Canada Nucleic Acid Extraction Instruments and Reagents Market
31. South America Nucleic Acid Extraction Instruments and Reagents Market
32. Brazil Nucleic Acid Extraction Instruments and Reagents Market
33. Middle East Nucleic Acid Extraction Instruments and Reagents Market
34. Africa Nucleic Acid Extraction Instruments and Reagents Market
36. Nucleic Acid Extraction Instruments and Reagents Market Competitive Landscape and Company Profiles
37. Nucleic Acid Extraction Instruments and Reagents Market Other Major and Innovative Companies
40. Nucleic Acid Extraction Instruments and Reagents Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Nucleic Acid Extraction Instruments And Reagents Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses nucleic acid extraction instruments and reagents market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for nucleic acid extraction instruments and reagents? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The nucleic acid extraction instruments and reagents market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Instruments; Spin Columns; Beads Or Magnetic Beads; Automated Nucleic Acid Extraction Systems; Extraction Kits And Reagents And Consumables; Other Types2) By Extraction Type: DNA Extraction; DNA Or RNA Extraction; RNA Extraction
3) By Method: Solution-Based Methods; Solid-Phase-Based Methods
4) By End User: Academic Research Institutes; Hospitals And Diagnostic Centers; Pharmaceutical And Biotechnology Industry; Contract Research Organizations (CROs); Other End Users
Subsegments:
1) By Instruments: Manual Extraction Instruments; Automated Extraction Instruments; Specialized Nucleic Acid Extractors2) By Spin Columns: Standard; High-Throughput; Specialized
3) By Beads Or Magnetic Beads: Silica-Based Beads; Magnetic Beads For DNA Or RNA Extraction; Functionalized Beads For Nucleic Acid Binding
4) By Automated Nucleic Acid Extraction Systems: Fully Automated Systems; Semi-Automated Systems
5) By Extraction Kits And Reagents And Consumables: DNA Extraction Kits; RNA Extraction Kits; Reagents For Nucleic Acid Purification; Consumables
6) By Other Types: Specialized Extraction Methods; Hybrid Methods
Companies Mentioned: Thermo Fisher Scientific Inc.; F Hoffmann-La Roche Ltd.; Merck Group; Corning Incorporated; Agilent Technologies Inc.; PerkinElmer; Beckman Coulter; Bio-Rad Laboratories Inc.; Qiagen NV; Eppendorf AG; LGC Biosearch Technologies; Promega Corporation; RBC Bioscience Corp.; Takara Bio Inc.; Meridian Bioscience; Bioneer Corporation; Macherey-Nagel; New England Biolabs; Miltenyi Biotec; Omega Bio-tek; BioVision Inc.; Norgen Biotek Corp.; Biosan Laboratories Inc.; G-Biosciences; ADS Biotec Inc.; BioChain Institute Inc.; Lucigen Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Nucleic Acid Extraction Instruments and Reagents market report include:- Thermo Fisher Scientific Inc.
- F Hoffmann-La Roche Ltd.
- Merck Group
- Corning Incorporated
- Agilent Technologies Inc.
- PerkinElmer
- Beckman Coulter
- Bio-Rad Laboratories Inc.
- Qiagen NV
- Eppendorf AG
- LGC Biosearch Technologies
- Promega Corporation
- RBC Bioscience Corp.
- Takara Bio Inc.
- Meridian Bioscience
- Bioneer Corporation
- Macherey-Nagel
- New England Biolabs
- Miltenyi Biotec
- Omega Bio-tek
- BioVision Inc.
- Norgen Biotek Corp.
- Biosan Laboratories Inc.
- G-Biosciences
- ADS Biotec Inc.
- BioChain Institute Inc.
- Lucigen Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 5.54 Billion |
| Forecasted Market Value ( USD | $ 8.78 Billion |
| Compound Annual Growth Rate | 12.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 27 |
